Today: 12 April 2026
Subscribe

Palantir’s Shocking Reinvention: From Secretive Spy Tech to $400B Cult Lifestyle Brand

Palantir Stock Whipsaws After ‘Otherworldly’ Q3—Has the 400% AI Rally Finally Met Its Match?

Palantir shares fell 6.9% pre-market to $192.97 after a record close, despite Q3 revenue jumping 63% to $1.18 billion and full-year guidance raised to as much as $4.40 billion. U.S. commercial revenue more than doubled. Investors cited concerns over valuation after a 400% rally and a projected Q4 growth slowdown to about 61%. Frankfurt-listed shares dropped 5.8%.
4 November 2025
··
Gold’s Epic Rally Ends With a Shock Slump: What’s Next for Bullion?

Gold Just Slipped Under $4,000—Then Bounced: Can Bulls Save 2025’s Record Run? (Nov 4, 2025)

Spot gold fell below $4,000/oz early Tuesday, touching $3,970/oz before rebounding to $3,994/oz by 12:10 GMT as the dollar and U.S. yields eased. December COMEX futures traded near $4,005/oz. Silver hovered at $47.80/oz, platinum at $1,558/oz, and palladium at $1,405/oz. The Fed cut rates last week but signaled no guarantee of another cut, with markets pricing a 65% chance for December.
4 November 2025
··
Vanguard’s Crypto U-Turn: $10T Giant Opens Doors to Bitcoin ETFs

‘Will $100K Break Today?’ Bitcoin Teeters as Shutdown Ties Record — Live Price, ETF Flows, Expert Calls (Nov 4, 2025)

Bitcoin dropped to $103,974 Tuesday, down 3.5% in 24 hours, after $1.4 billion in crypto liquidations and $186.5 million in U.S. spot BTC ETF outflows. The price is about 20% below its early-October record, with sellers testing $100,000 support. A record-length U.S. government shutdown and a stronger dollar are weighing on risk assets. Related stocks IBIT, FBTC, COIN, and MSTR also fell.
4 November 2025
····
European Stocks Climb Despite Shutdown Fears – Healthcare and Luxury Lead Gains

Wall Street on Edge: Bank Chiefs Warn 10–15% Pullback as Fed Flies Blind—Futures Slide, Big Tech Wobbles (Nov. 4, 2025)

S&P 500, Nasdaq-100, and Dow futures fell pre-market as bank CEOs warned of stretched tech valuations and possible drawdowns. The VIX hovered near a two-week high. Official U.S. economic data remained limited due to the government shutdown, with traders awaiting ADP’s jobs report. Palantir and Sarepta shares dropped, while Spotify rose; Uber fell on cautious guidance.
4 November 2025
················
Banks Warn of Bubble as AI Darling Palantir Plunges from Record High

Banks Warn of Bubble as AI Darling Palantir Plunges from Record High

Palantir shares fell about 7% Tuesday despite strong results, as analysts questioned its 246× forward earnings valuation after a 400% rally. Morgan Stanley and Goldman Sachs CEOs warned of a possible market pullback, citing stretched tech valuations. Major indexes slipped from record highs as Nvidia, Alphabet, and Amazon declined. Investors await more tech earnings and face uncertainty from a possible government shutdown and split Fed outlook.
4 November 2025
··
Pfizer’s Q3 Shocker: Earnings Beat, Outlook Raised, and a $7 Billion Obesity Drug Gambit

Pfizer’s Q3 Shocker: Earnings Beat, Outlook Raised, and a $7 Billion Obesity Drug Gambit

Pfizer reported Q3 2025 adjusted earnings of $0.87 per share, beating estimates, with revenue at $16.65–$16.7 billion. The company raised its full-year profit outlook to $3.00–$3.15 EPS. Sales of COVID products plunged, but demand for Eliquis and Vyndaqel rose. Pfizer sued Novo Nordisk over a $7.3 billion bid for obesity drugmaker Metsera; a court hearing is set for Nov. 4.
4 November 2025
···
Halliburton’s Big Comeback? Why Experts Say Oil Services Are ‘Down But Not Out’ in 2025

Halliburton’s Big Comeback? Why Experts Say Oil Services Are ‘Down But Not Out’ in 2025

Rothschild & Co Redburn initiated Halliburton with a Buy rating and $35 target, joining several firms raising price targets after strong Q3 results. Halliburton posted $5.6 billion in Q3 revenue, beating estimates, and is targeting $100 million in quarterly cost cuts. The company is expanding into data center power and automation amid weak U.S. shale spending. Shares trade near $27 as analysts forecast sector recovery by 2027.
4 November 2025
··
Shopify Q3 2025 Earnings: 32% Sales Surge, Bold Holiday Forecast – Is This Growth Stock Unstoppable?

Shopify Q3 2025 Earnings: 32% Sales Surge, Bold Holiday Forecast – Is This Growth Stock Unstoppable?

Shopify reported Q3 2025 revenue of $2.84 billion, up 32% year-over-year and above analyst estimates. Gross merchandise volume reached $92 billion, also rising 32%. Operating income climbed to $343 million, while free cash flow hit $507 million with an 18% margin. Shares fell about 3–4% pre-market after results, trading near $173 with a market cap over $220 billion.
4 November 2025
····
Grab Holdings (GRAB) Shocks with Q3 Beat & Forecast Hike – Stock Up 40% YTD, So Why the Post-Earnings Dip?

Grab Holdings (GRAB) Shocks with Q3 Beat & Forecast Hike – Stock Up 40% YTD, So Why the Post-Earnings Dip?

Grab shares fell about 9% to the mid-$5 range on Nov. 4, 2025, after Q3 earnings. Revenue rose 22% to $873 million, beating estimates, and net profit reached $17 million. The company raised its 2025 outlook, now guiding up to $3.40 billion in revenue. Monthly users climbed 14% to 47.7 million, with strong gains in food delivery and financial services.
4 November 2025
··
Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark shares plunged 14.6% on Nov. 3 to a 52-week low near $102 after announcing a $40 billion cash-and-stock deal to acquire Kenvue at a 46% premium. The drop erased about 15% of KMB’s market value, with the stock now down 21% year-over-year. Investors cited concerns over Kenvue’s litigation risks and debt load. KMB trades at 17.3× earnings, with a 4.9% dividend yield.
4 November 2025
··
New Fortress Energy Seeks U.K. Lifeline to Dodge Bankruptcy – Shares Crash as $9 B Debt Weighs

New Fortress Energy’s Wild Ride: 90% Crash, Debt Drama & a Surprise Rally – What’s Next for NFE Stock?

New Fortress Energy shares plunged over 90% year-to-date, closing at $1.18 on Nov. 3, before rebounding 32% in pre-market trading. The drop accelerated after reports of a UK debt restructuring plan to address $9 billion in liabilities and avoid U.S. bankruptcy. NFE faces “going concern” warnings ahead of Q3 earnings on Nov. 6, with analysts expecting another loss. The stock remains volatile amid contract wins and heavy downgrades.
4 November 2025
··
Sarepta Therapeutics (SRPT) Surges After FDA Greenlights Duchenne Gene Therapy – Is a Rebound Ahead?

Sarepta (SRPT) Stock Collapses 80% on FDA Bombshell – Is a Big Rebound Coming?

Sarepta Therapeutics shares plunged nearly 80% in 2025, falling from a high of $138.81 to around $15 after its Phase 3 ESSENCE trial failed and the FDA halted gene therapy trials following patient deaths. Q3 revenue beat estimates at $399.4 million, but the company posted a $179.9 million net loss. Sarepta restricted Elevidys sales to ambulatory patients after the FDA intervention. Analyst consensus is Hold, with a $34.50 average price target.
4 November 2025
··
PTL Limited (PTLE) Stock Soars on Surprise Profit Amid Delisting Risks – Key Facts & Outlook

PTL Limited (PTLE) Stock Soars on Surprise Profit Amid Delisting Risks – Key Facts & Outlook

PTL Limited (NASDAQ: PTLE) closed at $0.1861 on Nov 3, up 13%, then surged to $0.31 pre-market Nov 4 after reporting a surprise first-half profit of $1.21 million. The stock remains down about 97% year-to-date and faces Nasdaq delisting warnings. PTLE’s market cap stands near $7 million. Shares remain highly volatile, with a 52-week range of $0.14 to $15.78.
4 November 2025
·
Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Denny’s shares surged nearly 46% to $6.20 on Nov. 4, 2025, after announcing a $620 million go-private deal at $6.25 per share. The board approved the all-cash buyout by TriArtisan Capital, Treville Capital, and Yadav Enterprises, with closing expected by Q1 2026. Q3 revenue missed estimates at $113.2 million, and net income fell short at $0.6 million. Same-restaurant sales dropped 2.9% at Denny’s locations.
4 November 2025
···
UniQure’s Roller-Coaster: Gene Therapy Breakthrough, FDA Setback, and What’s Next for QURE Stock

UniQure Stock Plunges 50% on FDA Shocker – What’s Next for QURE’s Gene Therapy Ambitions?

uniQure shares plunged over 50% after the FDA said data for its Huntington’s disease gene therapy is not sufficient for approval, reversing earlier guidance. The stock dropped from about $68 to $34, wiping out roughly half its market value. Analysts called it a major regulatory setback, with some cutting price targets. Shareholder rights law firms launched investigations following the 57% one-day decline.
4 November 2025
·
Bitcoin Miner to AI Cloud Sensation: Why Iris Energy (IREN) Stock Is Soaring in 2025

From Bitcoin Miner to AI Cloud Powerhouse: Iris Energy’s Meteoric Rise (IREN Stock Soars on $9.7B Microsoft Deal)

Iris Energy (IREN) closed at $67.75 on Nov. 3, 2025, after announcing a $9.7 billion, five-year AI cloud contract with Microsoft, sending shares up 11.5%. The company’s market cap now tops $16.5 billion, up from $1 billion at the start of 2025. IREN posted FY2025 revenue of $501 million and net income of $86.9 million, driven by its pivot to AI cloud services and continued Bitcoin mining.
4 November 2025
···
Record 2026 Tax Refund Surge Looms as New Tax Cuts Fuel a $50 Billion “Stimulus”

Walmart Stock Soars on Tech & Holiday Buzz – Key Facts & Bold Predictions (Nov 2025 Update)

Walmart shares traded near $101.5 on November 4, close to a 52-week high and up 24% year-over-year. The company reported Q2 FY2026 net income of $7.2 billion, up 52%, and raised its full-year sales outlook. Walmart recently launched new AI shopping tools and partnered with Eli Lilly to offer discounted Zepbound. Wall Street remains bullish, with 31 of 32 analysts rating the stock a “Buy.”
4 November 2025
··
1 … 1,583 1,584 1,585 1,586 1,587 … 1,848

Stock Market Today

  • Revolution Medicines Price Target Raised by 11.57% to €116.43
    April 12, 2026, 2:18 AM EDT. Revolution Medicines (BIT:1RVMD) saw its average one-year price target increase by 11.57% to €116.43 per share from €104.36. Analyst targets range widely from €62.73 to €151.87. The new target price represents a potential gain of 39.44% over the latest closing price of €83.50. Institutional ownership has decreased by 10.18% to 188.7 million shares, with 391 funds reporting holdings, down 42.67% in the last quarter. Leading shareholders include Farallon Capital Management and Janus Henderson Group, both raising their portfolio allocations significantly. The shifts highlight mixed institutional sentiment despite the upward price forecast.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

11 April 2026
Snowflake shares fell 8.4% to $121.11 on Friday after an 11.7% drop Thursday, as investors sold off software stocks amid concerns over new AI tools from Anthropic and OpenAI. The stock now trades just above its 52-week low. The S&P 500 Software and Services Index is down 25.5% for the year. Snowflake reported fourth-quarter product revenue of $1.23 billion, up 30% from a year earlier.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 11.04.2026

11 April 2026
LIVEMarkets rolling coverageStarted: April 11, 2026, 12:00 AM EDTUpdated: April 11, 2026, 11:59 PM EDT DocuSign Stock Review: Is the 42% Yearly Drop a Buying Opportunity? April 11, 2026, 11:59 PM EDT. DocuSign (DOCU) shares have fallen 42.3% over the past year, raising questions about their value. Despite recent weakness, a Discounted Cash Flow (DCF) analysis suggests the stock is **68.1% undervalued**, with estimated intrinsic value around $134.42 versus a current price near $42.89. The DCF model projects growing free cash flows from $990 million in 2026 to $1.37 billion by 2029. Investors remain cautious amid evolving software spending trends
Go toTop